Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

148.77
+2.031.38%
Post-market: 149.000.2300+0.15%19:58 EDT
Volume:4.63M
Turnover:685.63M
Market Cap:184.58B
PE:-56.89
High:148.94
Open:146.60
Low:145.58
Close:146.74
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.74
T/O Rate:0.37%
Dividend:3.22
Dividend Rate:2.16%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.60
PE(LYR):21.94

Loading ...

Gilead Q2 FY26 Loss Per Share Widens to $(8.45); Revenue Rises 10% to $7.8 Billion

Reuters
·
Aug 05

GUIDANCE: (GILD) Gilead Sciences Expects Full Year 2026 Adjusted Loss Range of $0.30 - $0.65, vs. FactSet Est of $0.75 Loss

MT Newswires Live
·
Aug 05

Gilead Second-Quarter Sales Rise 8%, Beating Wall Street Estimates

Reuters
·
Aug 05

Gilead Sciences Q2 Adj. EPS $(6.75) Beats $(7.24) Estimate, Sales $7.803B Beat $7.400B Estimate

Benzinga Earnings
·
Aug 05

Gilead: Qtrly Adj EPS $-6.75 Reflecting $-9.08 Per Share Acquired Ipr&D and Tax Expenses Associated with Recent Acquisitions

THOMSON REUTERS
·
Aug 05

Gilead Sciences Inc Q2 Product Sales USD 7,627 Million

THOMSON REUTERS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Danaher (DHR) and Henry Schein (HSIC)

TIPRANKS
·
Aug 04

Rani Therapeutics Names Michelle Gilson to Board as Audit Committee Chair

Reuters
·
Aug 04

Gilead update on California ruling removes an overhang, says UBS

TIPRANKS
·
Aug 04

California Supreme Court Rules for Gilead in TDF Litigation

Reuters
·
Aug 04

California Supreme Court Rules in Favor of Gilead Sciences in 'Duty to Innovate' Case Involving Hiv Drugs

THOMSON REUTERS
·
Aug 04

Gilead’s GS-2426 Phase 1 Trial Targets MTAP-Deleted Tumors: What Investors Should Know

TIPRANKS
·
Aug 04

Eli Lilly Could Swing Over $76 Billion In Value After Earnings

Benzinga_recent_news
·
Aug 03

Compugen Publishes Corporate Presentation on AI-Driven Immuno-Oncology Antibody Pipeline

Reuters
·
Aug 03

Israel's Compugen Q2 Revenue More than Doubles, Net Loss Narrows

Reuters
·
Aug 03

Compugen Q2 FY26 Net Loss Narrows to USD 7 Million; Revenue More than Doubled to USD 2.6 Million

Reuters
·
Aug 03

Moderna Inc. Stock Slips 5.4%, Underperforms Peers

Dow Jones
·
Aug 01

Gilead Sciences Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 31

Gilead’s Twice-Yearly HIV Strategy: What the New Phase 3 Study Means for Investors

TIPRANKS
·
Jul 31

Movement Alert|Gilead Sciences Falls 3.02% in Regular Trading, Biotech Sector Broad Selloff Triggers Technical Pullback

Market Focus
·
Jul 30